Cebiotex offers manufacturing technology and contract research in the field of drug delivery with electrospun nanofiber technology.
Cebiotex – drug delivery with electrospun nanofiber technology
Cebiotex is the first spin-off company created by the collaboration of researchers at prominent institutions such as Universitat Politecnica de Catalunya and Hospital Sant Joan de Deu, both in Barcelona (Spain). This multidisciplinary team is made of experts in nanofiber engineering, preclinical pharmacology and drug delivery research. Cebiotex has developed and characterized, in vitro and in vivo, preclinical nonwoven nanofiber membranes for the controlled release of active agents for the local treatment of unresectable tumors. The purpose of local delivery improves the safety and efficacy of the active agents. Cebiotex assesses the activity, toxicity and pharmacokinetics of its products in preclinical models. Its membranes are also suitable to be applied by topical application, for instance for cosmetic purposes.
The technology for producing nonwoven nanofiber membranes relies on an optimized electrospinning process. Cebiotex has created from scratch an innovative machine which solves the common problems associated to industrial production of nanofibers, especially the reliability and reproducibility of the production. Cebiotex carries out the complete engineering of the production units as well as the pharmaceutical and preliminary medical test, thus notably improving the development time.
Cebiotex was launched in 2012 by researchers in nanofiber engineering at Universitat Politècnica de Catalunya and preclinical pharmacology and drug delivery at Hospital Sant Joan de Deu (Spain). 3 years of collaborative work enabled the development and preclinical characterization of innovative technologies and products for local drug delivery. Its inventions are protected by Cebiotex-licensed patent applications.
More about Cebiotex : www.cebiotex.com